VEON has partnered with Sechenov Medical University on behalf of its Russian telecom company Beeline on the use of artificial intelligence for the development of diagnostic drugs. This was announced by the telecom company with a listing on the Damrak on Monday, without mentioning any financial details.
Beeline’s technology will be used to detect damage to hip joints early, but also to identify kidney diseases and cancer variants.
Under the agreement, Beeline and Sechenov Medical University will jointly develop software and analysis tools.
